Atlas Trials

A Bidirectional Cohort Study of COMMD10 Expression in Tumor Tissues for Predicting Radiosensitivity

Clinical trial NCT06165224 · UNKNOWN

Trial details

NCT number
NCT06165224
Sponsor
Nanfang Hospital, Southern Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
BiomarkerRadiosensitivity
Start date
2023-12-01
Primary completion
2024-12-30
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.